Mergers & Acquisitions

  • November 06, 2025

    Skadden, Debevoise Lead Aquarian's $4.1B Brighthouse Buy

    Skadden and Debevoise are advising on a new agreement for Aquarian Capital to purchase U.S. life insurer Brighthouse Financial Inc. in an all-cash transaction valued at about $4.1 billion, the companies announced Thursday. 

  • November 06, 2025

    EchoStar Sells Spectrum Licenses To SpaceX In $2.6B Deal

    Telecommunications company EchoStar, led by White & Case LLP, announced Thursday that it agreed to sell certain licenses to Elon Musk-controlled SpaceX in a $2.6 billion stock deal that builds on a previous agreement they entered into earlier this year.

  • November 06, 2025

    Another Kirkland Investment Funds Atty Joins V&E In Houston

    Vinson & Elkins LLP has continued expanding its investment funds practice with a partner in Houston who is the third to join the practice from Kirkland & Ellis LLP since June.

  • November 06, 2025

    Shell, Equinor Merger Faces Enviro Calls For UK Tax Probe

    Environmentalist groups urged HM Treasury on Thursday to investigate the alleged £1.3 billion ($1.7 billion) tax savings that energy businesses Shell and Equinor will make if they merge their U.K. operations.

  • November 05, 2025

    DOJ Clears Google's $32B Deal To Buy Cybersecurity Co. Wiz

    Google's plan to acquire Wiz for $32 billion and integrate the growing cloud security platform into Google Cloud has cleared the U.S. Department of Justice's antitrust review, the tech giant confirmed Wednesday.

  • November 05, 2025

    AGs Defend Bid To Intervene In DOJ's HPE Merger Deal

    More than a dozen Democratic attorneys general have assailed the Justice Department and Hewlett Packard Enterprise for fighting their bid to peek behind the controversial settlement clearing HPE's $14 billion purchase of Juniper Networks, telling a California federal judge that Congress created court oversight for deals just like this.  

  • November 05, 2025

    FTC Wants 'Tainted' Drs. Testimony Barred From Merger Case

    The Federal Trade Commission wants a D.C. federal judge to bar a pair of outside doctors and consultants from vouching for Edwards Lifesciences' planned JenaValve acquisition, arguing in a filing made public Tuesday that claims of minimal communication between the physicians' counsel and the companies were "at best, misleading."

  • November 05, 2025

    Chancery Won't Let Pfizer Block $10B Novo Bid For Metsera

    A Delaware vice chancellor Wednesday refused Pfizer Inc.'s emergency bid for a temporary restraining order to block Metsera Inc. from closing a now $10 billion competing bid by Novo Nordisk for the GLP-1 weight-loss drugmaker, saying Pfizer hasn't demonstrated Metsera's board acted in bad faith or that the company would suffer immediate irreparable harm.

  • November 05, 2025

    EQT Gets Final OK For $168M Merger Benefits Settlement

    A federal court gave its final approval Tuesday to a $167.5 million settlement between EQT Corp. and its shareholders, closing out a class action that claimed the company overstated the operational benefits of its $6.7 billion merger with Rice Energy in 2017.

  • November 05, 2025

    Ex-Startup Exec Who Helped Defraud JPMorgan Gets 68 Mos.

    A Manhattan federal judge hit an Israeli businessman with 68 months in prison Wednesday for joining with Frank founder Charlie Javice to trick JPMorgan into buying their failed financial aid startup for $175 million by using faked customer data.

  • November 05, 2025

    Bain Capital Gives Perpetual's Wealth Business Another Go

    Australian investment manager Perpetual confirmed on Wednesday it is in exclusive talks with Bain Capital for a potential sale of its wealth management unit, which advises on about $14 billion. 

  • November 05, 2025

    4 Firms Shape $1.8B Senior Housing Operator Merger

    Sonida Senior Living Inc. is planning to buy CNL Healthcare Properties in a $1.8 billion cash-and-stock deal betting on senior housing demand as the country's over-80-years-old population is growing, with help from four law firms, the companies announced Wednesday.

  • November 05, 2025

    Kirkland Advises Fortress As Ripple Lands $500M Fundraise

    Crypto company Ripple announced Wednesday it secured a $500 million strategic investment at a $40 billion valuation, led by Fortress Investment Group along with affiliates of Citadel Securities, Pantera Capital, Galaxy Digital, Brevan Howard and Marshall Wace.

  • November 04, 2025

    Feds Tell 11th Circ. Delta, Aeromexico Can't Halt JV Split Order

    The Trump administration fired back at Delta Air Lines and Aeromexico's Eleventh Circuit bid to freeze a U.S. Department of Transportation order directing them to scuttle their joint venture by Jan. 1, saying the airlines' contention that it'd be too burdensome to disentangle their networks is overblown.

  • November 04, 2025

    Dechert Tracks Significant Decline In U.S. Merger Probes

    Dechert LLP's latest merger review report counted a dramatic decrease in the number of significant U.S. Department of Justice and Federal Trade Commission tie-up investigations between July and September and year-to-date, coming in at just two-thirds of the average over the last 15 years.

  • November 04, 2025

    EU Opens In-Depth Probe Of MMG's Nickel Mine Deal

    European enforcers have deepened a probe into MMG's planned purchase of Anglo American's nickel business in a deal worth up to $500 million, saying the Chinese state-backed mining company could divert supplies of a material needed for stainless steel production.

  • November 04, 2025

    Rare Earth Cos. Announce $1.4B Partnership With US Gov't

    Two companies said they have entered into a $1.4 billion joint partnership with the U.S. Department of Defense aimed at boosting the country's domestic rare earth magnet supply chain.

  • November 04, 2025

    Ex-View CFO Must Face SEC Suit Over Negligence Claim

    A California federal judge has ruled that the U.S. Securities and Exchange Commission has enough evidence to move forward with its negligence claim against a former chief financial officer of "smart" glassmaker View Inc. and that a jury should decide whether the related alleged misstatements were significant to investors.

  • November 04, 2025

    3 Firms Steer $1.45B Sale Of TriMas Aerospace

    Engineered products maker TriMas, advised by Jones Day, on Tuesday announced that it has agreed to sell its aerospace business to Goodwin Procter LLP-advised capital markets firm Tinicum LP in a $1.45 billion all-cash deal.

  • November 04, 2025

    Novo Nordisk Boosts Metsera Bid To $10B After Pfizer Suit

    Metsera Inc. said Tuesday its board has determined that a sweetened offer from Novo Nordisk is a superior proposal to its existing merger agreement with Pfizer Inc., as the pharmaceutical takeover battle continues amid revised bids and a pending lawsuit.

  • November 04, 2025

    Pfizer Can't Freeze $9B Weight-Loss Drug Fight For Now

    A Delaware vice chancellor on Tuesday declined for the moment Pfizer Inc.'s emergency request to put Novo Nordisk's $9 billion bid for Metsera Inc. on hold, saying the time isn't yet at hand for the court's intervention in a fight for control of the developer of GLP-1 weight-loss drugs.

  • November 04, 2025

    2 Firms Advise CBRE's $1.2B Pearce Services Deal

    Real estate services firm CBRE Group Inc. announced Tuesday that it acquired Pearce Services LLC, a service provider for electromechanical infrastructure in North America, from New Mountain Capital in a $1.2 billion deal guided by Sullivan & Cromwell LLP and Ropes & Gray LLP.

  • November 04, 2025

    2 Firms Guide $800M Intuitive-Lanteris Spacecraft Deal

    Intuitive Machines Inc., a space technology and infrastructure services company, said Tuesday it has agreed to acquire Lanteris Space Systems from Advent International for $800 million in a deal steered by Simpson Thacher & Bartlett LLP and Weil Gotshal & Manges, respectively.

  • November 04, 2025

    Blackstone Injecting $700M Into Merck Cancer Therapy

    Merck & Co. said Tuesday it will receive $700 million from Blackstone Life Sciences to help fund development of sacituzumab tirumotecan, an experimental antibody-drug conjugate targeting TROP2, a protein found on many cancer cells.

  • November 04, 2025

    5 Firms Steer Denny's $620M Go-Private Deal

    At least five law firms are helping to steer Denny's Corp.'s new agreement for the diner chain operator to go private through a $620 million sale to investment firms TriArtisan Capital Advisors and Treville Capital Group and Denny's franchise operator Yadav Enterprises.

Expert Analysis

  • FTC Focus: Enforcers Study AI Innovation And Entrenchment

    Author Photo

    The Federal Trade Commission and other regulators setting their sights on the burgeoning artificial intelligence ecosystem are considering how the government should approach innovation in tech markets that tend, almost inevitably, toward concentration, say attorneys at Proskauer.

  • 8 Ways Lawyers Can Protect The Rule Of Law In Their Work

    Author Photo

    Whether they are concerned with judicial independence, regulatory predictability or client confidence, lawyers can take specific meaningful actions on their own when traditional structures are too slow or too compromised to respond, says Angeli Patel at the Berkeley Center of Law and Business.

  • Assessing New Changes To Texas Officer Exculpation Law

    Author Photo

    Consistent with Texas' recent modernization of its corporate law, the recently passed S.B. 2411 allows officer exculpation, streamlines certificate of formation amendments, authorizes representatives to act on shareholders' behalf in mergers and makes other changes aimed toward companies seeking a more codified, statutory model of corporate governance, say attorneys at Bracewell.

  • Series

    Law School's Missed Lessons: Communicating With Clients

    Author Photo

    Law school curricula often overlook client communication procedures, and those who actively teach this crucial facet of the practice can create exceptional client satisfaction and success, says Patrick Hanson at Wiggam Law.

  • Series

    Adapting To Private Practice: From US Rep. To Boutique Firm

    Author Photo

    My transition from serving as a member of Congress to becoming a partner at a boutique firm has been remarkably smooth, in part because I never stopped exercising my legal muscles, maintained relationships with my former colleagues and set the right tone at the outset, says Mondaire Jones at Friedman Kaplan.

  • Spinoff Transaction Considerations For Biotech M&A

    Author Photo

    Amid current market challenges, boards and management teams of biotech companies can consider several strategies for maximizing value should a spinoff opportunity arise, but not without significant advance planning and careful implementation, particularly in cases that might qualify as tax-free, say attorneys at Paul Hastings.

  • Opinion

    Senate's 41% Litigation Finance Tax Would Hurt Legal System

    Author Photo

    The Senate’s latest version of the Big Beautiful Bill Act would impose a 41% tax on the litigation finance industry, but the tax is totally disconnected from the concerns it purports to address, and it would set the country back to a time when small plaintiffs had little recourse against big defendants, says Anthony Sebok at Cardozo School of Law.

  • Series

    Performing As A Clown Makes Me A Better Lawyer

    Author Photo

    To say that being a clown in the Macy’s Thanksgiving Day Parade has changed my legal career would truly be an understatement — by creating an opening to converse on a unique topic, it has allowed me to connect with clients, counsel and even judges on a deeper level, says Charles Tatelbaum at Tripp Scott.

  • Series

    Law School's Missed Lessons: Rejecting Biz Dev Myths

    Author Photo

    Law schools don’t spend sufficient time dispelling certain myths that prevent young lawyers from exploring new business opportunities, but by dismissing these misguided beliefs, even an introverted first-year associate with a small network of contacts can find long-term success, says Ronald Levine at Herrick Feinstein.

  • Del. Dispatch: General Partner Discretion In Valuing Incentives

    Author Photo

    In Walker v. FRP Investors, the Delaware Court of Chancery recently held that the general partner of a limited partnership breached its obligations when determining the threshold value of newly issued incentive units, highlighting the court's willingness to reconstruct what a reasonable determination of value by a general partner should have been, say attorneys at Fried Frank.

  • Move Beyond Surface-Level Edits To Master Legal Writing

    Author Photo

    Recent instances in which attorneys filed briefs containing artificial intelligence hallucinations offer a stark reminder that effective revision isn’t just about superficial details like grammar — it requires attorneys to critically engage with their writing and analyze their rhetorical choices, says Ivy Grey at WordRake.

  • How Ore. Law Puts New Confines On Corp. Health Ownership

    Author Photo

    A newly enacted law in Oregon strengthens the state’s restrictions on corporate ownership of healthcare practices, with new limitations on overlapping control, permissible services, restrictive covenants and more making it necessary for practices to review decades-old physician practice arrangements, say attorneys at Ropes & Gray.

  • Observations On 5 Years Of Non-Notified CFIUS Inquiries

    Author Photo

    Since 2020, the Committee on Foreign Investment in the United States has identified and investigated covered cross-border transactions not formally notified to CFIUS, and a look at data from 50 non-notified matters during that time reveals the general dynamics of this enforcement function, say attorneys at Cooley.

  • 9th Circ. Has Muddied Waters Of Article III Pleading Standard

    Author Photo

    District courts in the Ninth Circuit continue to apply a defunct and especially forgiving pleading standard to questions of Article III standing, and the circuit court itself has only perpetuated this confusion — making it an attractive forum for disputes that have no rightful place in federal court, say attorneys at Gibson Dunn.

  • Trump Antitrust Shift Eases Pressure On Private Equity Deals

    Author Photo

    Enforcement actions and statements by Trump administration antitrust officials forecast a shift away from specifically targeting private equity activity, which should be welcome news to dealmakers, but firms shouldn't expect to escape traditional antitrust scrutiny, says Nathaniel Bronstein at Fried Frank.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.